Gene: AGA
Official Full Name: aspartylglucosaminidaseprovided by HGNC
Gene Summary: This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03161 | AGA Knockout cell line (HeLa) | Human | AGA | 1:3~1:6 | Negative | Online Inquiry |
KO03162 | AGA Knockout cell line (HCT 116) | Human | AGA | 1:2~1:4 | Negative | Online Inquiry |
KO03163 | AGA Knockout cell line (HEK293) | Human | AGA | 1:3~1:6 | Negative | Online Inquiry |
KO03164 | AGA Knockout cell line (A549) | Human | AGA | 1:3~1:4 | Negative | Online Inquiry |
AGA Gene Knockout Cell Lines are specifically engineered biological tools designed to study the function and regulation of the AGA gene, which encodes for the enzyme α-galactosidase A. These cell lines have undergone precise genetic modifications to silence or disrupt the expression of the AGA gene, enabling researchers to elucidate the pathways and impact of its absence on cellular function and disease processes.
The primary mechanism of action involves homologous recombination, a precise genetic engineering technique that allows for targeted gene disruption. This results in the loss of AGA enzymatic activity, thereby facilitating the investigation of phenotypic changes induced by knockout. Researchers can utilize these cell lines to model lysosomal storage diseases, particularly Fabry disease, leading to potential new therapeutic approaches by analyzing metabolic pathways and evaluating drug efficacy.
The scientific importance of AGA Gene Knockout Cell Lines lies in their capacity to serve as invaluable models in both basic and applied research settings. They allow for the study of pathophysiological mechanisms linked to AGA deficiency and provide essential data for the development of enzyme replacement therapies and gene therapy techniques. In clinical environments, these cell lines can be used to screen potential pharmacological agents, thereby accelerating translational research efforts.
Unique advantages of AGA Gene Knockout Cell Lines compared to alternative models include their specificity in gene targeting and robustness in modeling human pathologies. These cell lines are generated using cutting-edge CRISPR/Cas9 technology, which ensures high efficiency and reproducibility, and can be customized further for various experimental needs.
For researchers and clinicians seeking to advance their understanding of metabolic disorders, AGA Gene Knockout Cell Lines offer a powerful asset in dissecting gene function and exploring innovative treatment modalities. Our company brings extensive experience in the production and optimization of genetically modified cell lines, ensuring that customers receive high-quality, reliable products that stand at the forefront of genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.